Menu
A screenshot of PhRMA's paper
The Pharmaceutical Research and Manufacturers of America is pushing for a 340B rebate model in a new paper.

PhRMA Pushes For a 340B Rebate Model as 340B Health Lobbies on the Hill

Luke Zarzecki, National Correspondent 340B Report Views
A powerful drug industry trade group alleged in a new paper that the 340B program’s growth is tied to fraud [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

J&J Adds Two Drugs to 340B Contract Pharmacy Restrictions, Tells Providers to Self-Identify MFP Overpayments

U.S. Senate Report Highlights Medicaid Drug Pricing Loophole that 340B Experts Warn Could Affect Provider Savings

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live